BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Biotech Bay

  Veeva Systems, Inc. Unites Best-of-Breed Cloud And Video Capabilities To Deliver Seamless Digital Engagement Between Life Sciences And Healthcare Professionals

  October 4, 2016

   · 

  5 min read
• Business

  Veeva Systems, Inc. Brings Together Real-time Collaboration And Compliance In The Cloud With Microsoft Office Online

  October 4, 2016

   · 

  4 min read
• Drug Development

  Amgen Release: Study Results Published In Journal Of Clinical Oncology Show BLINCYTO (Blinatumomab) Induced Complete Remission In Heavily Pretreated Pediatric Patients With Philadelphia Chromosome-Negative Relapsed Or Refractory B-Cell Precursor Acute Lym

  October 4, 2016

   · 

  17 min read
• Genetown

  Study Published By Journal Of Diabetes Science And Technology Demonstrates Glytec LLC’s Superiority In Meeting ADA Guidelines

  October 4, 2016

   · 

  5 min read
• Biotech Bay

  IncellDx, Inc.’s Quantitative Immuno-Oncology Assay OncoTect iO Published In New Study

  October 4, 2016

   · 

  2 min read
• Business

  Chengdu’s HitGen Collaborates With Janssen Biotech On Oncology And Metabolics Discovery

  October 4, 2016

   · 

  1 min read
• Business

  Mobidiag Announces Agency Agreement With YouMed For The Commercialization Of Its Molecular Diagnostic Product Line Amplidiag In UK

  October 4, 2016

   · 

  2 min read
• Drug Development

  FDA Grants Breakthrough Therapy Designation For Genentech (Hillsboro)’s Alecensa (Alectinib) For First-Line Treatment Of People With ALK-Positive NSCLC

  October 4, 2016

   · 

  8 min read
• Drug Development

  Chugai Pharma’s Alecensa Receives Breakthrough Therapy Designation From FDA For First-Line Treatment Of ALK Positive Non-Small Cell Lung Cancer

  October 4, 2016

   · 

  6 min read
• PHARNEXT Announces Support Of The First Patient-Centered Charcot-Marie-Tooth Summit Organized By The Hereditary Neuropathy Foundation

  October 4, 2016

   · 

  4 min read